Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial was for people whose acute myeloid leukaemia had not responded to treatment or had come back after the first treatment.
Recruitment start: 17 December 2010
Recruitment end: 25 September 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jonathan Kell
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sunesis Pharmaceuticals Inc
Last reviewed: 4 July 2017
CRUK internal database number: 8405
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
